AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
05 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
04 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
03 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
02 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
01 Aug 2011 03:00 PM
RNS
Total Voting Rights
01 Aug 2011 07:00 AM
RNS
Transaction in Own Shares
29 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 3 of 3
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 2 of 3
28 Jul 2011 07:00 AM
RNS
Second Quarter Results 2011 - Part 1 of 3
28 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
27 Jul 2011 09:00 AM
RNS
Notice of Results
27 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
26 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
25 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
22 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
21 Jul 2011 07:00 AM
RNS
FDA approves Brilinta for use in the US
21 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
20 Jul 2011 07:00 AM
RNS
FDA advisors make recommendation on dapagliflozin
20 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
19 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
18 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
15 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
14 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
13 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
12 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
11 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
08 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
07 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
06 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
05 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
04 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
01 Jul 2011 03:00 PM
RNS
Total Voting Rights
01 Jul 2011 07:00 AM
RNS
Nexium gets first approval in Japan
01 Jul 2011 07:00 AM
RNS
Transaction in Own Shares
30 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
29 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
28 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
27 Jun 2011 07:00 AM
RNS
Announces Phase3 study with BMS on Dapagliflozin
27 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
24 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
23 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
22 Jun 2011 07:00 AM
RNS
Sells Astra Tech to Dentsply International
22 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
21 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
20 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
17 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
16 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
15 Jun 2011 04:00 PM
RNS
Director/PDMR Shareholding
15 Jun 2011 07:00 AM
RNS
Transaction in Own Shares
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100